Stealth BioTherapeutics Competitors and Similar CompaniesClear all
Stealth BioTherapeutics's competitors and similar companies include Oxford BioTherapeutics and Cogent Biosciences.
 Stealth BioTherapeutics Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction. |  Oxford BioTherapeutics Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs. |  Cogent Biosciences Cogent Biosciences (formerly known as Unum Therapeutics) is a biotechnology company that designs precision therapies to treat genetically driven diseases. | |
Founding Date | Founding Date 2007 | Founding Date 2004 | Founding Date 2014 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Newton, US HQ Needham, US | Locations Milton, GB HQ San Jose, US | Locations Waltham, US HQ Boulder, US |
Employees | Employees 592% decrease | Employees 51 | Employees 16419% increase |
Valuation ($) | Valuation ($) 18.4 m | Valuation ($) N/A | Valuation ($) 1.3 b |
Financial | |||
Net income | Net income ($52.5m) (FY, 2021) | Net income (£6.5m) (FY, 2018) | Net income ($192.4m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised $ 100m | Total funding raised $ 21.6m | Total funding raised $ 178.3m |
For sources of this data, please see the company profile
View Company Profiles
Oxford BioTherapeutics
HQ
Milton, GB
Employees
51
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
View companyCogent Biosciences
HQ
Waltham, US
Employees
164↑ 19% increase
Cogent Biosciences (formerly known as Unum Therapeutics) is a biotechnology company that designs precision therapies to treat genetically driven diseases.
View company